Van Buren D - Search Results

1

The Neoral formulation: improved correlation between cyclosporine trough levels and exposure in stable renal transplant recipients.

Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Chang C, Choc M, et al. Kahan BD, et al. Among authors: van buren d. Transplant Proc. 1994 Oct;26(5):2940-3. Transplant Proc. 1994. PMID: 7940928 Clinical Trial. No abstract available.

2

Reduced inter- and intrasubject variability in cyclosporine pharmacokinetics in renal transplant recipients treated with a microemulsion formulation in conjunction with fasting, low-fat meals, or high-fat meals.

Kahan BD, Dunn J, Fitts C, Van Buren D, Wombolt D, Pollak R, Carson R, Alexander JW, Choc M, Wong R, et al. Kahan BD, et al. Among authors: van buren d. Transplantation. 1995 Feb 27;59(4):505-11. Transplantation. 1995. PMID: 7878754 Clinical Trial.

3

The antagonistic effect of rifampin upon cyclosporine bioavailability.

Van Buren D, Wideman CA, Ried M, Gibbons S, Van Buren CT, Jarowenko M, Flechner SM, Frazier OH, Cooley DA, Kahan BD. Van Buren D, et al. Among authors: van buren ct. Transplant Proc. 1984 Dec;16(6):1642-5. Transplant Proc. 1984. PMID: 6390878 No abstract available.

4

Impact of Sandimmune, Neoral, and Prograf on rejection incidence and renal function in primary liver transplant recipients.

Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW. Van Buren D, et al. Transplant Proc. 1998 Aug;30(5):1830-2. doi: 10.1016/s0041-1345(98)00448-5. Transplant Proc. 1998. PMID: 9723299 Clinical Trial.

5

De novo hemolytic uremic syndrome in renal transplant recipients immunosuppressed with cyclosporine.

Van Buren D, Van Buren CT, Flechner SM, Maddox AM, Verani R, Kahan BD. Van Buren D, et al. Among authors: van buren ct. Surgery. 1985 Jul;98(1):54-62. Surgery. 1985. PMID: 3892747

6

Renal function in primary liver transplant recipients receiving neoral (cyclosporine) versus prograf (tacrolimus).

Van Buren D, Payne J, Geevarghese S, MacDonell R, Chapman W, Wright JK, Helderman JH, Richie R, Pinson CW. Van Buren D, et al. Transplant Proc. 1998 Jun;30(4):1401-2. doi: 10.1016/s0041-1345(98)00289-9. Transplant Proc. 1998. PMID: 9636566 Clinical Trial.

7

Immediate effect of intravenous cyclosporine on hepatic hemodynamics.

Lopez RR, Van Buren DH, Wright JK, Drougas JG, Barnard SE, Stokes KA, Pinson CW. Lopez RR, et al. Among authors: van buren dh. Transplant Proc. 1996 Aug;28(4):2241-3. Transplant Proc. 1996. PMID: 8769212 No abstract available.

8

Cyclosporine improves results in HLA-identical sibling renal transplants.

Van Buren D, MacDonell R, Johnson HK, Richie R, Ynares C, Helderman JH, Green W, Crowe D. Van Buren D, et al. Transplant Proc. 1994 Oct;26(5):2514-5. Transplant Proc. 1994. PMID: 7940772 Clinical Trial. No abstract available.

9

Kidney transplantation at extremes of age: CsA eliminates the increased risk in recipients < or = 5 or > or = 55 years.

MacDonell RC Jr, Van Buren DH, Richie RE, Johnson HK, Nylander WA, Helderman JH, Ynares CM, Trusler LA, Green WF, Crowe DA. MacDonell RC Jr, et al. Among authors: van buren dh. Transplant Proc. 1994 Oct;26(5):2518-21. Transplant Proc. 1994. PMID: 7940774 No abstract available.

10

Experience with neoral versus sandimmune in primary liver transplant recipients.

Pinson CW, Chapman WC, Wright JK, Hunter EB, Awad JA, Raiford DS, Payne JL, Geevarghese S, Blair TK, Van Buren DH. Pinson CW, et al. Among authors: van buren dh. Transpl Int. 1998;11 Suppl 1:S278-83. doi: 10.1007/s001470050479. Transpl Int. 1998. PMID: 9664997 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

77 results

Search Page

Filters